US 12365728
DLL3 single domain antibodies and therapeutic compositions thereof
granted A61KA61K2039/505A61K2239/55
Quick answer
US patent 12365728 (DLL3 single domain antibodies and therapeutic compositions thereof) held by Inhibrx Biosciences, Inc. expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx Biosciences, Inc.
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/505, A61K2239/55, A61K40/11, A61K40/4202